中国老年结直肠肿瘤患者围手术期管理专家共识(2020版)

2020-08-30 中国医师协会结直肠肿瘤专委会 中华结直肠疾病电子杂志.2020.9(4):325-334.

结直肠肿瘤是高发恶性肿瘤,其发病率随年龄增长而逐渐增高。从全世界范围来看,每年50% 新增结直肠肿瘤患者均为70 岁以上老年患者,其中25% 是80 岁以上高龄患者。老年患者术前多有合并症,因而围手术

中文标题:

中国老年结直肠肿瘤患者围手术期管理专家共识(2020版)

发布日期:

2020-08-30

简要介绍:

结直肠肿瘤是高发恶性肿瘤,其发病率随年龄增长而逐渐增高。从全世界范围来看,每年50% 新增结直肠肿瘤患者均为70 岁以上老年患者,其中25% 是80 岁以上高龄患者。老年患者术前多有合并症,因而围手术期风险更高。此外,老年患者通常伴有更晚期的局部肿瘤病灶,其在就诊时往往已发生肠道梗阻或病变转移,导致手术操作难度加大。现已明确,高龄是增加围手术期病死率的独立危险因素。因此,为了更好地应对老年肿瘤患者围术期管理挑战,由中国医师协会结直肠肿瘤专业委员会围术期医学专委会的相关专家制定老年结直肠肿瘤患者围术期管理专家共识,从术前、术中和术后三个不同围术期阶段入手,围绕老年结直肠肿瘤患者术前综合评估、预康复措施、肺保护性通气策略、目标导向液体治疗、区域阻滞镇痛管理、术后认知功能障碍防治等重点问题进行探讨,以进一步提高老年结直肠肿瘤患者围术期管理水平,加速患者术后康复,改善患者预后。

相关资料下载:
[AttachmentFileName(sort=1, fileName=中国老年结直肠肿瘤患者围手术期管理专家共识_2020版_张国华.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d35311c0019e5041, title=中国老年结直肠肿瘤患者围手术期管理专家共识(2020版), enTitle=, guiderFrom=中华结直肠疾病电子杂志.2020.9(4):325-334., authorId=0, author=, summary=结直肠肿瘤是高发恶性肿瘤,其发病率随年龄增长而逐渐增高。从全世界范围来看,每年50% 新增结直肠肿瘤患者均为70 岁以上老年患者,其中25% 是80 岁以上高龄患者。老年患者术前多有合并症,因而围手术, cover=https://img.medsci.cn/2020923/1600871513541_2020535.jpg, journalId=0, articlesId=null, associationId=1825, associationName=中国医师协会结直肠肿瘤专委会, associationIntro=, copyright=0, guiderPublishedTime=Sun Aug 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>结直肠肿瘤是高发恶性肿瘤,其发病率随年龄增长而逐渐增高。从全世界范围来看,每年50% 新增结直肠肿瘤患者均为70 岁以上老年患者,其中25% 是80 岁以上高龄患者。老年患者术前多有合并症,因而围手术期风险更高。此外,老年患者通常伴有更晚期的局部肿瘤病灶,其在就诊时往往已发生肠道梗阻或病变转移,导致手术操作难度加大。现已明确,高龄是增加围手术期病死率的独立危险因素。因此,为了更好地应对老年肿瘤患者围术期管理挑战,由中国医师协会结直肠肿瘤专业委员会围术期医学专委会的相关专家制定老年结直肠肿瘤患者围术期管理专家共识,从术前、术中和术后三个不同围术期阶段入手,围绕老年结直肠肿瘤患者术前综合评估、预康复措施、肺保护性通气策略、目标导向液体治疗、区域阻滞镇痛管理、术后认知功能障碍防治等重点问题进行探讨,以进一步提高老年结直肠肿瘤患者围术期管理水平,加速患者术后康复,改善患者预后。</p> </div> </div> </div>, tagList=[TagDto(tagId=9119, tagName=结直肠肿瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=19, categoryName=老年医学, tenant=100), CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=9119, guiderKeyword=结直肠肿瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6855, appHits=284, showAppHits=0, pcHits=761, showPcHits=6571, likes=1, shares=29, comments=18, approvalStatus=1, publishedTime=Wed Sep 23 23:08:53 CST 2020, publishedTimeString=2020-08-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Sep 23 22:32:01 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 13:05:03 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国老年结直肠肿瘤患者围手术期管理专家共识_2020版_张国华.pdf)])
中国老年结直肠肿瘤患者围手术期管理专家共识_2020版_张国华.pdf
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1223885, encodeId=2b3712238859b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17de8188648, createdName=gong0815, createdTime=Wed Jun 01 16:42:01 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213930, encodeId=f4fd1213930d4, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22d65600482, createdName=ms5000001928427756, createdTime=Sun Apr 24 16:41:24 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976934, encodeId=94b99e693422, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66b75534476, createdName=ms6000000079288216, createdTime=Sat Jun 26 00:08:45 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921746, encodeId=fb00921e4622, content=很详细,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b401707400, createdName=1de95b52m21(暂无匿称), createdTime=Sun Jan 31 20:24:50 CST 2021, time=2021-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915963, encodeId=2dd0915963c6, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 12 17:57:49 CST 2021, time=2021-01-12, status=1, ipAttribution=)]
    2022-06-01 gong0815

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1223885, encodeId=2b3712238859b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17de8188648, createdName=gong0815, createdTime=Wed Jun 01 16:42:01 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213930, encodeId=f4fd1213930d4, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22d65600482, createdName=ms5000001928427756, createdTime=Sun Apr 24 16:41:24 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976934, encodeId=94b99e693422, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66b75534476, createdName=ms6000000079288216, createdTime=Sat Jun 26 00:08:45 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921746, encodeId=fb00921e4622, content=很详细,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b401707400, createdName=1de95b52m21(暂无匿称), createdTime=Sun Jan 31 20:24:50 CST 2021, time=2021-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915963, encodeId=2dd0915963c6, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 12 17:57:49 CST 2021, time=2021-01-12, status=1, ipAttribution=)]
    2022-04-24 ms5000001928427756

    挺好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1223885, encodeId=2b3712238859b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17de8188648, createdName=gong0815, createdTime=Wed Jun 01 16:42:01 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213930, encodeId=f4fd1213930d4, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22d65600482, createdName=ms5000001928427756, createdTime=Sun Apr 24 16:41:24 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976934, encodeId=94b99e693422, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66b75534476, createdName=ms6000000079288216, createdTime=Sat Jun 26 00:08:45 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921746, encodeId=fb00921e4622, content=很详细,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b401707400, createdName=1de95b52m21(暂无匿称), createdTime=Sun Jan 31 20:24:50 CST 2021, time=2021-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915963, encodeId=2dd0915963c6, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 12 17:57:49 CST 2021, time=2021-01-12, status=1, ipAttribution=)]
    2021-06-26 ms6000000079288216

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1223885, encodeId=2b3712238859b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17de8188648, createdName=gong0815, createdTime=Wed Jun 01 16:42:01 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213930, encodeId=f4fd1213930d4, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22d65600482, createdName=ms5000001928427756, createdTime=Sun Apr 24 16:41:24 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976934, encodeId=94b99e693422, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66b75534476, createdName=ms6000000079288216, createdTime=Sat Jun 26 00:08:45 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921746, encodeId=fb00921e4622, content=很详细,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b401707400, createdName=1de95b52m21(暂无匿称), createdTime=Sun Jan 31 20:24:50 CST 2021, time=2021-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915963, encodeId=2dd0915963c6, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 12 17:57:49 CST 2021, time=2021-01-12, status=1, ipAttribution=)]
    2021-01-31 1de95b52m21(暂无匿称)

    很详细,值得学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1223885, encodeId=2b3712238859b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17de8188648, createdName=gong0815, createdTime=Wed Jun 01 16:42:01 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213930, encodeId=f4fd1213930d4, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22d65600482, createdName=ms5000001928427756, createdTime=Sun Apr 24 16:41:24 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976934, encodeId=94b99e693422, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66b75534476, createdName=ms6000000079288216, createdTime=Sat Jun 26 00:08:45 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921746, encodeId=fb00921e4622, content=很详细,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b401707400, createdName=1de95b52m21(暂无匿称), createdTime=Sun Jan 31 20:24:50 CST 2021, time=2021-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915963, encodeId=2dd0915963c6, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 12 17:57:49 CST 2021, time=2021-01-12, status=1, ipAttribution=)]
    2021-01-12 jyzxjiangqin

    好共识!

    0